These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 21322955
21. Orally active benzoxazole derivative as 5-HT3 receptor partial agonist for treatment of diarrhea-predominant irritable bowel syndrome. Yoshida S, Shiokawa S, Kawano K, Ito T, Murakami H, Suzuki H, Sato Y. J Med Chem; 2005 Nov 03; 48(22):7075-9. PubMed ID: 16250667 [Abstract] [Full Text] [Related]
22. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model. Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M. J Pharmacol Exp Ther; 2007 Sep 03; 322(3):1315-23. PubMed ID: 17540858 [Abstract] [Full Text] [Related]
23. [Effects of oculo-acupuncture therapy on colonic serotonin reuptake transporter expression in rats with irritable bowel syndrome]. Song SY, Wang YJ, Wang DS, Chai JY. Zhen Ci Yan Jiu; 2011 Apr 03; 36(2):101-4, 115. PubMed ID: 21717776 [Abstract] [Full Text] [Related]
26. [Pharmacokinetics study on costunolide and dehydrocostuslactone after administration of traditional Chinese medicine Weichang'an pills]. Zhang JZ, Wang L, Jin ZX, Qu Z, Chen YL, Gao WY. Zhongguo Zhong Yao Za Zhi; 2015 Mar 03; 40(6):1173-8. PubMed ID: 26226766 [Abstract] [Full Text] [Related]
27. [Regulatory effect of anthraquinone derivatives from rhubarb on aquaporin 4 expression in colon of rats and in LoVo cell line]. Zhang WS, Li F, Bao JQ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep 03; 28(9):818-23. PubMed ID: 19065897 [Abstract] [Full Text] [Related]
28. Effects of Wei Chang An pill on enzyme activity and levels of vasoactive peptide and substance P in the small intestine of rats with compound diarrhea. Hu R, Tang F. J Tradit Chin Med; 2012 Mar 03; 32(1):52-7. PubMed ID: 22594102 [Abstract] [Full Text] [Related]
29. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome]. Li MR, Jiang K, Zhang QY. Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966 [Abstract] [Full Text] [Related]
30. Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Wang G, Li TQ, Wang L, Xia Q, Chang J, Zhang Y, Wan MH, Guo J, Cheng Y, Huang X, Zhang RM. Chin Med J (Engl); 2006 Dec 20; 119(24):2114-9. PubMed ID: 17199964 [No Abstract] [Full Text] [Related]
31. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome. Long Y, Liu Y, Tong J, Qian W, Hou X. Eur J Pharmacol; 2010 Jun 25; 636(1-3):159-65. PubMed ID: 20371236 [Abstract] [Full Text] [Related]
32. Effect of Tongxieyaofang decoction on colonic mucosal protein expression profiles in rats with visceral hypersensitivity. Lin Y, Ding Y, Lü B, Liu N. J Tradit Chin Med; 2020 Apr 25; 40(2):245-252. PubMed ID: 32242390 [Abstract] [Full Text] [Related]
34. The antibacterial activity of Berberis heteropoda Schrenk and its effect on irritable bowel syndrome in rats. Li L, Zhu HM, Yan Q, Li SY, Li F. Chin J Nat Med; 2020 May 25; 18(5):356-368. PubMed ID: 32451093 [Abstract] [Full Text] [Related]
36. [Role of serotonin in the pathophysiology of the irritable bowel syndrome]. Moskwa A, Boznańska P. Wiad Lek; 2007 May 25; 60(7-8):371-6. PubMed ID: 18175558 [Abstract] [Full Text] [Related]
37. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, Cirino G, Wallace JL, Fiorucci S. J Pharmacol Exp Ther; 2006 Oct 25; 319(1):447-58. PubMed ID: 16855178 [Abstract] [Full Text] [Related]
38. Intestinal permeability and irritable bowel syndrome. Camilleri M, Gorman H. Neurogastroenterol Motil; 2007 Jul 25; 19(7):545-52. PubMed ID: 17593135 [Abstract] [Full Text] [Related]
39. Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S. Proteomics; 2010 Jul 25; 10(14):2620-30. PubMed ID: 20461717 [Abstract] [Full Text] [Related]
40. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope]. Kong WM, Gong J, Dong L, Chen MX. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 25; 27(8):1167-70, 1172. PubMed ID: 17715017 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]